Withanoside V
Based on 1 Customer Validation
Withanoside V is a blood-brain barrier-permeable withanolide derivative. Withanoside V binds strongly to Sudlow I (domain IIA) of human serum albumin (HSA) to form a stable complex and alter the secondary structure of albumin, thereby increasing helix content and reducing β-sheet and random coil. Withanoside V binds to Aβ (1-42) to block the interaction between monomers and subsequent aggregation. Withanoside V inhibits the viability of neuroblastoma cells, reduces the number of apoptotic cells induced by Aβ (1-42), and decreases ROS production. Withanoside V inhibits SARS-CoV-2 Mpro. Withanoside V can be used for research on Alzheimer's disease and coronavirus disease 2019.
For research use only. We do not sell to patients.
- Purity : 99.9%
- CAS No.: 256520-90-8
- Formula: C40H62O14
- Molecular Weight:766.91
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
Description
In Vitro
Withanoside V binds tightly to human serum albumin with a Ks of 5.33 × 104 M-1, and binds to Sudlow's site I (domain IIA) of human serum albumin with a Ks of 4.8 × 104 M-1, inducing conformational changes in human serum albumin[1].
Withanoside V (100 μM; 6-72 h) inhibits the aggregation of Aβ (1-42) in vitro and reduces the formation of β-sheet-rich oligomers and fibrils over an incubation period of up to 72 h[2].
Withanoside V (10-100 μM; 24-48 h) inhibits the viability of SK-N-SH cells with an IC50 of 30.14 μM, and protects SK-N-SH cells from Aβ (1-42)-induced cytotoxic damage[2].
Withanoside V (15.07 μM; 24 h) increases the proportion of early apoptotic cells in human SK-N-SH neuroblastoma cells while maintaining a high overall cell viability[2].
Compared with cells treated with Aβ (1-42), Withanoside V (15.07 μM; 24 h) reduces the level of DNA fragmentation and the number of apoptotic cells in human SK-N-SH neuroblastoma cells[2].
Withanoside V (15.07 μM; 24 h) significantly reduces Aβ (1-42)-induced intracellular ROS production in human SK-N-SH neuroblastoma cells[2].
Withanoside V is a SARS-CoV-2 Mpro inhibitor with a binding affinity of -8.96 kcal/mol. It forms stable hydrogen bonds at the active site of this enzyme, and its mechanism of action is similar to that of the natural N3 inhibitor[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:human SK-N-SH neuroblastoma cells
-
Concentration:0, 20, 40, 60, 80, 100 μM/15.07 μM
-
Incubation Time:48 h/24 h
-
Result:Exhibited dose-dependent cytotoxicity against SK-N-SH cells, with an IC50 value of 30.14 μM after 48 h.
Increased neuronal cell viability significantly when cells were pre-treated with amyloid-β(1-42) then treated with half the IC50 concentration, indicating neutralization of amyloid-β(1-42)-induced cytotoxicity.
-
Cell Line:human SK-N-SH neuroblastoma cells
-
Concentration:15.07 μM (half IC50)
-
Incubation Time:24 h
-
Result:Resulted in 93.2% viable cells, 0.9% dead cells, 5.2% early apoptotic cells, and 0.7% late apoptotic cells, compared to untreated controls with 96.1% viable cells, 1.3% dead cells, 2.2% early apoptotic cells, and 0.4% late apoptotic cells.
Chemical Information
-
CAS No. 256520-90-8
-
Appearance Solid
-
Molecular Weight 766.91
-
Formula C40H62O14
-
Color White to off-white
-
SMILES
C[C@]1(CC2)[C@](CC[C@]1([H])[C@@H]([C@@](OC3=O)([H])CC(C)=C3C)C)([H])[C@@](CC=C4C[C@H]5O[C@@H]([C@@H]([C@H]6O)O)O[C@@H]([C@H]6O)CO[C@@H]([C@@H]([C@H]7O)O)O[C@@H]([C@H]7O)CO)([H])[C@@]2([H])[C@]4([C@H](C5)O)C
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Alzheimer’s Disease Modeling
Alzheimer’s Disease (AD) is a neurodegenerative disorder characterized by a progressive decline in cognitive functions and loss of specific types of neurons and synapses. Alzheimer's symptoms can be simulated in mice by injecting drugs (such as Aβ) or genetically modified.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
-
Data Sheet (275 KB)
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
-
Handling Instructions (2659 KB)
References
[1]. Dubey S, et al. Elucidating the active interaction mechanism of phytochemicals withanolide and withanoside derivatives with human serum albumin. PLoS One. 2018;13(11):e0200053. Published 2018 Nov 7. [Content Brief]
[2]. Dubey S, et al. Improving the inhibition of β-amyloid aggregation by withanolide and withanoside derivatives. Int J Biol Macromol. 2021;173:56-65. [Content Brief]
[3]. Matsuda H, et al. Structures of withanosides I, II, III, IV, V, VI, and VII, new withanolide glycosides, from the roots of Indian Withania somnifera DUNAL. and inhibitory activity for tachyphylaxis to clonidine in isolated guinea-pig ileum. Bioorg Med Chem. 2001 Jun;9(6):1499-507. [Content Brief]
[4]. Choe J, et al. The Efficacy of Traditional Medicinal Plants in Modulating the Main Protease of SARS-CoV-2 and Cytokine Storm. Chem Biodivers. 2022;19(11):e202200655. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Withanoside V
- 256520-90-8
- Amyloid-β
- Apoptosis
- Reactive Oxygen Species (ROS)
- SARS-CoV
- withanolide derivative
- SARS-CoV-2 main protease
- human SK-N-SH neuroblastoma cells
- human serum albumin
- Alzheimer's disease
- amyloid-β 42
- apoptosis
- blood-brain barrier
- Sudlow's drug binding site I
- reactive oxygen species
- coronavirus disease 2019
- Inhibitor
- inhibitor
- inhibit